Race, Genetics and a Controversy
By Alan Goodman, Marcy Darnovsky, et. al.,
New York Times
| 04. 02. 2018
To the Editor:
In “‘Race’ in the Age of Modern Genetics” (Sunday Review, March 25), David Reich does a disservice to the many scientists and scholars who have demonstrated the scientific flaws of considering “race” a biological category.
This robust body of scholarship recognizes the existence of geographically based genetic variation in our species, but shows that such variation is not consistent with biological definitions of race. Nor does that variation map precisely onto ever-changing, socially defined racial groups.
This doesn’t mean that genetic variation is unimportant; it is, even if it does not follow racial lines. But history has taught us that studies of human genetic variation can be misunderstood and misinterpreted if sampling practices and historical contexts are not considered; if little attention is given to how genes, environments and social conditions interact; and if we ignore the ways that sociocultural categories and practices shape the genetic patterns themselves.
As applied to human beings, race is a social grouping. Genetically, there is only one human race.
ALAN GOODMAN
MARCY DARNOVSKY
AMHERST, MASS.
Dr. Goodman is a...
Related Articles
By Arthur Lazarus, MedPage Today | 01.23.2026
A growing body of contemporary research and reporting exposes how old ideas can find new life when repurposed within modern systems of medicine, technology, and public policy. Over the last decade, several trends have converged:
- The rise of polygenic scoring...
By Stephanie Pappas, LiveScience | 01.15.2026
Genetic variants believed to cause blindness in nearly everyone who carries them actually lead to vision loss less than 30% of the time, new research finds.
The study challenges the concept of Mendelian diseases, or diseases and disorders attributed to...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...
By Josie Ensor, The Times | 12.09.2025
A fertility start-up that promises to screen embryos to give would-be parents their “best baby” has come under fire for a “misuse of science”.
Nucleus Genomics describes its mission as “IVF for genetic optimisation”, offering advanced embryo testing that allows...